Ignite Creation Date:
2024-05-05 @ 5:23 PM
Last Modification Date:
2024-10-26 @ 9:31 AM
Study NCT ID:
NCT00448279
Status:
COMPLETED
Last Update Posted:
2014-10-24
First Post:
2007-03-15
Brief Title:
THOR Study A Study of Continued Herceptin Trastuzumab in Combination With Second Line Chemotherapy in Patients With HER2 Positive Metastatic Breast Cancer
Sponsor:
Organization:
Hoffmann-La Roche